These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6389896)

  • 21. Does effect of a neuroprotective agent on volume of experimental animal cerebral infarct predict effect of the agent on clinical outcome in human stroke?
    Jonas S; Tran AQ; Eisenberg E; Azam M; Viera D; Grumet S
    Ann N Y Acad Sci; 1997 Oct; 825():281-7. PubMed ID: 9369994
    [No Abstract]   [Full Text] [Related]  

  • 22. Early effects of GM1 in experimental cerebral focal ischemia in rabbits.
    Bo P; Marchioni E; Soragna D; Savoldi F
    Boll Soc Ital Biol Sper; 1993 Nov; 69(11):705-10. PubMed ID: 8060600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Agents to improve cerebrovascular circulation and cerebral metabolism--cellryl].
    Hasegawa T
    Nihon Rinsho; 1985 Feb; 43(2):392-6. PubMed ID: 3889413
    [No Abstract]   [Full Text] [Related]  

  • 24. Can functional reorganization of area 17 following monocular deprivation be modified by GM1 internal ester treatment?
    Carmignoto G; Canella R; Bisti S
    J Neurosci Res; 1984; 12(2-3):477-83. PubMed ID: 6502761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Betamethasone therapy in acute cerebrovascular accidents.
    Gupta RC; Bhatnagar HN; Gambhir MS; Shah DR
    J Assoc Physicians India; 1978 Jul; 26(7):589-94. PubMed ID: 363681
    [No Abstract]   [Full Text] [Related]  

  • 26. [Controlled clinical study of use of dihydroergocristine in cerebral and periferal vascular disorders].
    Calisti G; Biscarini L; Miseo A
    Clin Ter; 1977 Nov; 83(4):371-86. PubMed ID: 414875
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical evaluation of GABA in the treatment of cerebrovascular disorders. Multi-center double-blind study in comparison with pyrithioxine and placebo.
    Otomo E; Araki G; Mori A; Kurihara M
    Arzneimittelforschung; 1981; 31(9):1511-23. PubMed ID: 7030354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A double-blind controlled clinical study on the use of mucopolysaccharides in the treatment of patients with cerebral vasculopathy. Comparison with a placebo].
    Bardin P; Campo R
    Clin Ter; 1987 Jan; 120(2):111-8. PubMed ID: 2972439
    [No Abstract]   [Full Text] [Related]  

  • 29. [Trials of monosialoganglioside (Sygen) treatment in ischemic stroke].
    Wender M; Mularek J; Godlewski A; Losy J; Michałowska-Wender G; Sniatała-Kamasa M; Wójcicka M
    Neurol Neurochir Pol; 1993; 27(1):31-8. PubMed ID: 8502357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trial of ganglioside GM1 in acute stroke.
    Hoffbrand BI; Bingley PJ; Oppenheimer SM; Sheldon CD
    J Neurol Neurosurg Psychiatry; 1988 Sep; 51(9):1213-4. PubMed ID: 3066849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of dexamethasone phosphate in cerebral infarction compared with current standard therapy. Controlled double-blind method].
    Rompel C; Krämer W; Umlauf B; Ulm K; Hellhake T
    Med Welt; 1980 Sep; 31(38):1370-2. PubMed ID: 7432136
    [No Abstract]   [Full Text] [Related]  

  • 32. Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage.
    Toyoda K; Okada Y; Minematsu K; Kamouchi M; Fujimoto S; Ibayashi S; Inoue T
    Neurology; 2005 Oct; 65(7):1000-4. PubMed ID: 16217049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pilot study of streptokinase for acute cerebral infarction.
    Morris AD; Ritchie C; Grosset DG; Adams FG; Lees KR
    QJM; 1995 Oct; 88(10):727-31. PubMed ID: 7493170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GM1 ganglioside therapy in acute ischemic stroke. Italian Acute Stroke Study--Hemodilution + Drug.
    Argentino C; Sacchetti ML; Toni D; Savoini G; D'Arcangelo E; Erminio F; Federico F; Milone FF; Gallai V; Gambi D
    Stroke; 1989 Sep; 20(9):1143-9. PubMed ID: 2672425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and baseline results of the monosialoganglioside early stroke trial. The EST Study Group.
    Rocca WA; Dorsey FC; Grigoletto F; Gent M; Roberts RS; Walker MD; Easton JD; Bruno R; Carolei A; Sancesario G
    Stroke; 1992 Apr; 23(4):519-26. PubMed ID: 1561683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monosialoganglioside GM1 and modulation of neuronal plasticity in CNS repair processes.
    Skaper SD; Mazzari S; Vantini G; Facci L; Toffano G; Leon A
    Adv Exp Med Biol; 1991; 296():257-66. PubMed ID: 1781332
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical applications of pharmacologic therapies for spinal cord injury.
    Zeidman SM; Ling GS; Ducker TB; Ellenbogen RG
    J Spinal Disord; 1996 Oct; 9(5):367-80. PubMed ID: 8938604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alteplase for thrombolysis in acute ischemic stroke.
    Med Lett Drugs Ther; 1996 Nov; 38(987):99-100. PubMed ID: 8914507
    [No Abstract]   [Full Text] [Related]  

  • 39. New approach to treatment of recent stroke?
    Perkin GD
    Br Med J; 1979 May; 1(6173):1283. PubMed ID: 378323
    [No Abstract]   [Full Text] [Related]  

  • 40. [Compressed spectral EEG analysis of patients with acute cerebral circulatory disorders].
    Gusev EI; Fedin AI; Erokhn OIu; Shvarts IP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(8):1133-41. PubMed ID: 7315046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.